| group A (n = 63) | Group B (n = 65) | Group C (n = 68) |
---|---|---|---|
COS | |||
 Dosage of rFSH (IU) | 2476.31 ± 379.34 | 2556.69 ± 419.57 | 2586.90 ± 587.63 |
 Duration of COS (d) | 9.89 ± 2.85 | 9.68 ± 2.22 | 9.33 ± 2.34 |
 E2 on trigger day (pg/mL) | 756.95 ± 191.65 | 740.23 ± 180.47 | 721.03 ± 151.62 |
 Endometrial thickness (mm) | 9.10 ± 1.89 | 8.95 ± 1.91 | 8.81 ± 1.61 |
 Number of oocytes retrieved | 2.98 ± 0.67 | 2.82 ± 0.87 | 2.68 ± 0.90 |
 Number of MII | 2.54 ± 0.94 | 2.43 ± 0.79 | 2.37 ± 0.74 |
 Number of 2PN ab | 2.08 ± 0.93 | 1.87 ± 0.87 | 1.36 ± 0.58 |
 Number of transplantable embryos ab | 2.02 ± 0.57 | 1.85 ± 0.71 | 1.22 ± 0.49 |
 Cancel cycle rate (%) | 11.11% (7/63) | 12.31% (8/65) | 23.53% (16/68) |
ET | |||
 Number of embryos per ET | 1.43 ± 0.50 | 1.44 ± 0.50 | 1.33 ± 0.47 |
 Implantation rate (%) ab | 30.00% (24/80) | 24.39% (20/82) | 10.14% (7/69) |
 Clinical pregnancy rate (%) ab | 37.50% (21/56) | 29.82% (17/57) | 11.54% (6/52) |
 Miscarriage rate (%) | 9.52% (2/21) | 23.53% (4/17) | 33.33% (2/6) |
 Multiple pregnancy rate (%) | 14.29% (3/21) | 17.65% (3/17) | 16.67% (1/6) |
In FF | |||
 GDF9 (pg/ml) abc | 1020 ± 117 | 904 ± 70 | 671 ± 53 |
 BMP15 (pg/ml) abc | 666 ± 40 | 643 ± 46 | 420 ± 40 |